NPPA fixes ceiling prices of 9 scheduled formulations, check out details

New Delhi: Through a recent notice Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and the National Pharmaceutical Pricing Authority (NPPA) has fixed/revised ceiling prices/Retail Prices of 9 scheduled formulations of Schedule-I under Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST)

Below is the details of the ceilings. Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

Sl. No.	Name of the Scheduled Formulation	Dosage form & Strength	Unit	Ceiling Price (Rs.)
(1)	(2)	(3)	(4)	(5)
1.	Midazolam	Tablet 7.5mg	1 Tablet	20.37
2.	Benzyl penicillin	Powder for Injection 10 Lac Units	Each Pack	4.72
3.	Para-aminosalicylic acid	Granules (As licensed)	1 Gram	2.58
4.	Ifosfamide	Powder for Injection 2g	Each Pack	861.83
5.	Cloxacillin	Tablet 250mg	1 Tablet	1.57
6.	Rifabutin	Tablet 150mg	1 Tablet	33.61
7.	Cloxacillin	Capsule 250mg	1 Capsule	1.02
8.	Cloxacillin	Capsule 500mg	1 Capsule	1.72

In addition

Sl. No.	Name of the Scheduled Formulation	Dosage form & Strength	Unit	Ceiling Price (Rs.)	Review Order number and date	Existing SO number and date
(1)	(2)	(3)	(4)	(5)	(6)	(7)
1.	Ibuprofen	Oral Liquid 100mg/5ml	1 ML	0.17935	31015/1/2017-PI.I dated 18.04.2017	2058(E) dated 30.6.2017 (at Sl. No. 300)

Note:

• All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.


• All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.


• The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.


• The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form-V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.


• As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.


• Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.


• The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.


• The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.


• Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above tablein this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Find the attachments for the same.

http://www.nppaindia.nic.in/ceiling/press11august17/so27042017e81-11-08-17_1.pdf

http://www.nppaindia.nic.in/ceiling/press11august17/01so27042017e2-11-08-17_2.pdf

http://www.nppaindia.nic.in/ceiling/press11august17/01so27042017e2-11-08-17_3.pdf

Medical Dialogues had earlier reported that NPPA had fixed/revised ceiling prices/Retail Prices of 67 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order,2016 under DPCO, 2013, exclusive of goods and services tax.

Read also: NPPA fixes ceiling prices of 67 scheduled formulations